Real world registration study of one million cases on 'Taiji' Huoxiang Zhengqi Oral liquid.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800015077

Enrollment

Unknown

Registered

2018-03-06

Start date

2018-03-12

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal cold?common cold due to wind-cold? Summer dampness and so on.

Interventions

one group:'Taiji' Huoxiang Zhengqi Oral liquid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who have been prescribed by Huoxiang zhengqi Oral liquid in medical institution; 2. Willing to participate in the research and sign a consent form.

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

Measure	Time frame
the time of disease recovery;the time of main symptom disappeared;	—

Secondary

Measure	Time frame
remission rate;Clinical syndrome integral;Main symptom disappearance rate;	—

Countries

China

Contacts

Public ContactYu Shuguang

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

ysg28588@126.com+86 028 61800000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026